Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
2-(3-Chlorophenyl)-2-methylpropan-1-amine was used for the preparation of pyrimidinediones as antagonists of L-type calcium channels (LTCC) for potential use in the treatment of Parkinson’s disease.
您的位置：
